Clinical study offer

🫁 Paid Tuberculosis Clinical Trials

Browse recruiting tuberculosis clinical trials across the United States. Find eligibility information, locations and research opportunities near you.

Loading...
Active Studies
Tuberculosis
Condition

Active Clinical Trials for Tuberculosis

Showing live studies from ClinicalTrials.gov. Data refreshes daily.

Loading studies...

Disclaimer: This content is for educational purposes and is not medical advice. Always consult a qualified healthcare provider for medical guidance.

About Tuberculosis

Tuberculosis (TB) is a serious bacterial infection primarily affecting the lungs but can spread to other organs. Clinical trials investigate shorter treatment regimens, drug-resistant TB therapies, and improved vaccine candidates.

Common Symptoms

Persistent cough (lasting 3+ weeks), coughing up blood, chest pain, fever, night sweats, weight loss, fatigue, loss of appetite

Risk Factors

Close contact with TB patients, HIV infection, immunocompromised status, living or traveling to endemic areas, poverty, malnutrition, homelessness, incarceration

Treatment Overview

Treatment involves a multi-month regimen of antibiotics including rifampin, isoniazid, pyrazinamide, and ethambutol. Clinical trials explore shorter all-oral regimens, novel antibiotics for multidrug-resistant TB, and host-directed therapies.

Why Participate?

Tuberculosis clinical trials help develop shorter, more tolerable treatment regimens to improve completion rates and combat drug-resistant TB globally.

Related Conditions

States with Tuberculosis Clinical Trials

Cities with Tuberculosis Clinical Trials

Frequently Asked Questions About Tuberculosis Clinical Trials

Tuberculosis clinical trials test new antibiotic combinations and shorter treatment regimens to improve cure rates and reduce drug resistance. Studies include both drug-sensitive and drug-resistant TB.
Eligibility depends on TB type (pulmonary, extrapulmonary), drug susceptibility, treatment history, and HIV status. Some studies focus on latent TB infection.
Compensation varies. Participants may receive $50-$150 per visit with study medications and monitoring provided at no cost.
Yes, participants receive regular monitoring including sputum tests and chest imaging. All trials have safety oversight and ethics approval.